Adel G Bishai, MD in Emporia, VA - General Practice

Adel G Bishai, MD is a General Practice physician based in Emporia, Virginia. Adel G Bishai is licensed to practice in Virginia (license number 0101039644) and his current practice location is 6 Doctors Dr, Emporia Medical Associates Pc, Emporia, Virginia. He can be reached at his office (for appointments etc.) via phone at (434) 634-6101.

NPI number for Adel G Bishai is 1760425052 and his current mailing address is 6 Doctors Dr, Emporia Medical Associates Pc, Emporia, Virginia. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1760425052.

Contact Information

	Adel G Bishai, MD
	6 Doctors Dr, Emporia Medical Associates Pc, Emporia, VA 23847-1240
	(434) 634-6101
	Not Available

Physician's Profile

Full Name	Adel G Bishai
Gender	Male
Speciality	General Practice
Location	6 Doctors Dr, Emporia, Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1760425052
Provider Enumeration Date: 06/14/2006
Last Update Date: 11/04/2011

Medical Identifiers

Medical identifiers for Adel G Bishai such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1760425052	NPI	-	NPPES
187120	Other	VA	BLUE SHIELD
9534853	Other		CIGNA
005699754	Medicaid	VA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	0101039644 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Adel G Bishai is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Adel G Bishai, MD 6 Doctors Dr, Emporia Medical Associates Pc, Emporia, VA 23847-1240 Ph: (434) 634-6101	Adel G Bishai, MD 6 Doctors Dr, Emporia Medical Associates Pc, Emporia, VA 23847-1240 Ph: (434) 634-6101

News Archive

Gene delivery strategy to help improve muscle mass in patients with degenerative muscle disorders

Severe weakness of the quadriceps is a defining feature of several neuromuscular disorders. Researchers at Nationwide Children's Hospital have shown that a gene delivery strategy that produces follistatin - a naturally occurring protein that inhibits myostatin, a growth factor expressed specifically in skeletal muscle - directly to the quadriceps of non-human primates results in long-term gene expression with muscle enhancing effects, including larger muscles with greater strength.

Researchers identify genetic variants associated with severe skin reactions to antiepileptic drug

Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin, according to a study in the August 6 issue of JAMA.

BD reports adjusted revenues of $3.133 billion for third fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly adjusted revenues of $3.133 billion for the third fiscal quarter ended June 30, 2015, an increase of 45.2 percent over the prior-year period as reported, or 55.6 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 2.4 percent. As reported, revenues were $3.120 billion.

Text message reminders led to timely HPV vaccine series completion, reports study

Text message reminders led to timely HPV vaccine series completion across a low-income, urban, minority population, according to a new study.

New stem cell treatment may halt clinical relapses, development of new brain lesions in patients MS

A new use of chemotherapy followed by autologous haematopoietic stem cell transplantation (aHSCT) has fully halted clinical relapses and development of new brain lesions in 23 of 24 patients with multiple sclerosis (MS) for a prolonged period without the need for ongoing medication, according to a new phase 2 clinical trial, published in The Lancet.

Adel G Bishai, MD - General Practice in Emporia, VA